Skip to main content

Table 1 Participant timeline from initial screening to end of study

From: Ergothioneine supplementation in people with metabolic syndrome (ErgMS): protocol for a randomised, double-blind, placebo-controlled pilot study

  1. at1, baseline; t2, 6 weeks, t3 12 weeks
Back to article page

Pilot and Feasibility Studies

ISSN: 2055-5784